FOMDWebPartPage

2010 Publications

  1. Douglas DN, Kawahara T, Sis B, Bond D, Fischer KP, Tyrrell DL, Lewis JT, Kneteman NM: Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease. PLoS ONE 5:e9209, 2010
  2. Einecke G, Kayser D, Vanslambrouck JM, Sis B, Reeve J, Mengel M, Famulski KS, Bailey CG, Rasko JEJ, Halloran PF: Loss of solute carriers in T cell mediated rejection in mouse and human kidneys: An active epithelial injury – repair response. Am J Transplant 10:2241-2251, 2010
  3. Einecke G, Reeve J, Sis B, Mengel M, Hidalgo L, Famulski K, Matas A, Kasiske B, Kaplan B, Halloran P: A molecular classifier for predicting future graft loss in late kidney transplant biopsies. The Journal of Clinical investigation 120:1862-1872, 2010
  4. Famulski KS, Kayser D, Einecke G, Allanach K, Badr D, Venner J, Sis B., Halloran PF: Alternative macrophage activation is associated with parenchymal deterioration in T cell mediated rejection of mouse kidneys. Am J Transplant 10:490-497, 2010
  5. Famulski KS, Einecke G, Sis B, Mengel M, Hidalgo LG, Kaplan B, Halloran PF: Defining the Canonical Form of T-Cell-Mediated Rejection in Human Kidney Transplants. Am J Transplant 10:810-820, 2010
  6. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ: Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplant 90:68-74, 2010
  7. Gebel HM, Halloran PF: Making sense of desensitization. Am J Transplant 10:443-444, 2010
  8. Gourishankar S, Leduc R, Connett J, Cecka JM, Cosio F, Fieberg A, Gaston R, Halloran P, Hunsicker L, Kasiske B, Rush D, Grande J, Mannon R, Matas A: Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study. Am J Transplant 10:324-330, 2010
  9. Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, Reeve J, Sellares J, Sis B: The molecular phenotype of kidney transplants. Am J Transplant 10:2215-2222, 2010
  10. Halloran PF: Commemorating the 10th anniversary of the launch of the AJT project.[Erratum appears in Am J Transplant. 2010 Jun;10(6):1496]. Am J Transplant 10:1111, 2010
  11. Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, Reeve J, Sellares J, Sis B: An integrated view of molecular changes, histopathology, and outcomes in kidney transplants. Am J Transplant 10:2223-2230, 2010
  12. Halloran PF: T Cell Mediated Rejection of Kidney Transplants: A Personal Viewpoint. Am J Transplant 10:1126-1134, 2010
  13. Halloran PF: T cell-mediated rejection of kidney transplants: a personal viewpoint. [Review] [58 refs]. Am J Transplant 10:1126-1134, 2010
  14. Hidalgo LG, Halloran PF: Better the Devil You Know: Response to Professor Ponticelli and Colleagues. Am J Transplant 10:1333, 2010
  15. Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF: NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 10:1812-1822, 2010
  16. Mannon RB, Matas AJ, Grande J, Leduc R, Connett J, Kasiske B, Cecka JM, Gaston RS, Cosio F, Gourishankar S, Halloran PF, Hunsicker L, Rush D: Inflammation in Areas of Tubular Atrophy in Kidney Allograft Biopsies: A Potent Predictor of Allograft Failure. Am J Transplant 10:2066-2073, 2010
  17. Matas AJ, Leduc R, Rush D, Cecka JM, Connett J, Fieberg A, Halloran P, Hunsicker L, Cosio F, Grande J, Mannon R, Gourishankar S, Gaston R, Kasiske B: Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study. Am J Transplant 10:315-323, 2010
  18. Mengel M, Sis B, Kim D, Chang J, Famulski K, Hidalgo L, Einecke G, De Freitas D, Tymchak W, Burton J, Halloran PF: The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant 10:2105-2115, 2010
  19. Sis B, Halloran PF: Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 15:42-48, 2010
  20. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen L, Solez K, Baldwin W.M. I, Bracamonte E, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon R, Nankivell B, Nickeleit V, Papadimetriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska B, Zachary AA, Zeevi A: Banff '09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups. Am J Transplant 10:464-471, 2010
  21. Sis B, Einecke G, Chang J, Hidalgo LG, Mengel M, Kaplan B, Halloran PF: Cluster analysis of lesions in kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation, and scarring. Am J Transplant 10:421-430, 2010
  22. Vincenti F, Blancho G, Durrbach A, Friend P, Grinyo J, Halloran PF, Klempnauer J, Lang P, Larsen CP, Muhlbacher F, Nashan B, Soulillou JP, Vanrenterghem Y, Wekerle T, Agarwal M, Gujrathi S, Shen J, Shi R, Townsend R, Charpentier B: Five-Year Safety and Efficacy of Belatacept in Renal Transplantation. J Am Soc Nephrol 21:1587-1596, 2010
  23. Chahal M, Xu Y, Lesniak D, Graham K, Famulski K, Christensen JG, Aghi M, Jacques A, Murray D, Sabri S, Abdulkarim B. MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib. Neuro Oncol. 2010 Aug;12(8):822-33.